Effects of an Integrated Multimodal Lifestyle Intervention for Management of Violence in Schizophrenia
NCT ID: NCT05229484
Last Updated: 2022-04-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
62 participants
INTERVENTIONAL
2016-08-15
2018-08-14
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of a Community-based LAI-treated Management Model on the Violence Risk of Patients With Schizophrenia
NCT03080194
Effects of Integrated Moral Reasoning Development Intervention for Management of Violence in Schizophrenia
NCT05207319
Aggressive Acts Among Patients With Schizophrenia
NCT00172497
Lifestyle Redesign For Schizophrenia
NCT04430868
Efficacy of Chronic Disease Self-management Program in People With Schizophrenia
NCT04503954
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention Group: an integrated multimodal lifestyle intervention (MLifeI)
The MLifeI program focused on the roles of health responsibility, review of lipid profile, complications of imbalanced lipid profile, lipid management and nutritional education.
an integrated multimodal lifestyle intervention (MLifeI)
The MLifeI program focused on the roles of health responsibility, review of lipid profile, complications of imbalanced lipid profile, lipid management and nutritional education.
Control group
The control group is the Treatment as Usual (TAU).
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
an integrated multimodal lifestyle intervention (MLifeI)
The MLifeI program focused on the roles of health responsibility, review of lipid profile, complications of imbalanced lipid profile, lipid management and nutritional education.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Psychiatrically hospitalized
* Repetitive violence within one year
* Ambulatory
* Having basic literacy
* More than 20 years old
* Less than 65 years old
Exclusion Criteria
* Physical co-morbidity or life-threatening illnesses that may impact on lipid homeostasis
* dietary restrictions for physical condition
* pregnancy
* reported disabilities
* impairments or health illness/problems that significantly limited their ability to perform the intervention such as severe arthritis, uncorrected visual or hearing impairments, developmental disability, or signs of intellectual disability.
20 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
I-Shou University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mei-Chi Hsu
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mei-Chi Hsu, Ph.D
Role: PRINCIPAL_INVESTIGATOR
I-Shou University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
I-Shou University
Kaohsiung City, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IShouU-cholesterol I
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.